CELFULL® is an AI-driven biotechnology company founded in California, USA. By integrating AI-powered technologies with systems biology, CELFULL explores science-based ingredients, formulations and therapeutic approaches related to healthy aging, with the goal of supporting longer health span.
CELFULL has established an integrated research ecosystem comprising the Aging Mechanism Research Platform, AI Network Pharmacology Platform, Turn A® Delivery Technology Platform, and Product Evaluation & Clinical Research Platform. Together, these platforms support research across biological mechanisms, formulation and delivery technologies, product evaluation, and clinical studies.
NAD+ and NADH-based aging intervention are among CELFULL’s key research areas in longevity science. To address the stability and delivery challenges associated with NADH, CELFULL continues to explore the science and applications of stable NADH through technologies including the Turn A® delivery platform and Celfavor® microsphere technology.
CELFULL is committed to translating advances in longevity science into science-based health solutions that support cellular health, vitality, and healthy aging.
For more information please visit our website.